Re: Groth et al.: SALT Trial: steroids after laser trabeculoplasty: impact of short-term anti-inflammatory treatment on selective laser trabeculoplasty efficacy (Ophthalmology. 2019;126:1511-1516).
No abstract available for this article.
More by Tobias Dahlgren
View full profile →Optimal Performance of Selective Laser Trabeculoplasty: Results from the Swedish Optimal SLT Multicenter Randomized Controlled Trial.
The impact of topical NSAID treatment on selective laser trabeculoplasty efficacy.
Predictors of Selective Laser Trabeculoplasty Efficacy: Results from the Swedish Optimal Selective Laser Trabeculoplasty Multicenter Randomized Controlled Trial.
Top Research in Laser Treatment
Browse all →Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension.
Selective laser trabeculoplasty: past, present, and future.
Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial.
In the Knowledge Library
Discussion
Comments and discussion will appear here in a future update.